Viatris (VTRS) Dividends Paid - Common (2021 - 2026)
Viatris (VTRS) recorded quarterly Dividends Paid - Common of $139.6 million in Q1 2026, up 1.01% quarter-over-quarter from $138.2 million in Q4 2025, and down 2.58% on a YoY basis from $143.3 million in Q1 2025.
Viatris (VTRS) Dividends Paid - Common (2021 - 2026) Analysis & Trends
Viatris' Dividends Paid - Common history runs 6 years deep, the most recent figure standing at $139.6 million for Q1 2026.
- In Q1 2026, Dividends Paid - Common fell 2.58% year-over-year to $139.6 million; the TTM figure through Mar 2026 stood at $557.5 million (down 3.09% YoY), while the FY2025 annual figure was $561.2 million, down 2.37% from the prior year.
- Dividends Paid - Common was $139.6 million for Q1 2026 at Viatris, up from $138.2 million in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $145.5 million in Q2 2022 to a low of $138.2 million in Q4 2025.
- Historically, Dividends Paid - Common has averaged $143.1 million across 5 years, with a median of $143.8 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Dividends Paid - Common grew 9.4% in 2022, then retreated 3.92% in 2025.
- A 5-year view of Dividends Paid - Common shows it stood at $145.5 million in 2022, then retreated by 1.03% to $144.0 million in 2023, then decreased by 0.49% to $143.3 million in 2024, then fell by 3.56% to $138.2 million in 2025, then rose by 1.01% to $139.6 million in 2026.
- The last three Dividends Paid - Common figures came in at $139.6 million (Q1 2026), $138.2 million (Q4 2025), and $139.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 224.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Viatris | - | - | 1.16 Bn | 139.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.60 Mn |
| Mar 31, 2026 | 139.60 Mn |
| Dec 31, 2025 | 138.20 Mn |
| Dec 31, 2025 | 138.20 Mn |
| Sep 30, 2025 | 139.90 Mn |
| Sep 30, 2025 | 139.90 Mn |
| Jun 30, 2025 | 139.80 Mn |
| Jun 30, 2025 | 139.80 Mn |
| Mar 31, 2025 | 143.30 Mn |
| Mar 31, 2025 | 143.30 Mn |
| Dec 31, 2024 | 143.30 Mn |
| Dec 31, 2024 | 143.30 Mn |
| Sep 30, 2024 | 143.20 Mn |
| Sep 30, 2024 | 143.20 Mn |
| Jun 30, 2024 | 145.50 Mn |
| Jun 30, 2024 | 145.50 Mn |
| Mar 31, 2024 | 142.80 Mn |
| Mar 31, 2024 | 142.80 Mn |
| Dec 31, 2023 | 144.00 Mn |
| Dec 31, 2023 | 144.00 Mn |